John A. Taylor, III, MD, MS

University of Kansas – Kansas City, KS

Dr. John A Taylor, III is the John W Weigel Endowed Professor of Urology & Cancer Biology, Director of Basic Urologic Research and the Co-Leader of the D3ET Program at the University of Kansas Medical Center. He earned his B.A. from Lafayette College and M.D. from Columbia University College of Physicians & Surgeons. He completed residency training at Columbia University’s Presbyterian Medical Center and obtained a Master’s of Science Degree in Clinical and Translational Research at the University of Connecticut.  Dr. Taylor’s practice and research efforts are focused on bladder cancer. He has been supported by the National Institutes of Health, Department of Defense, American Cancer Society, American Geriatrics Society, and American Urological Association. He is the President and Director of the Leo & Anne Albert Institute for Bladder Cancer Care and Research.

Dr. Taylor’s lab focuses on pathway analysis (inflammation, aging) related to carcinogenesis and novel drug development and biomarker discovery. His research team is recognized nationally as an expert in bladder cancer pre-clinical modeling and is routinely sought by academia and industry for collaboration.

I became involved in BCAN starting with the 2010 Think Tank in Traverse City, Michigan as it was the only organization that solely focused on both the science and care of bladder cancer.  I am very optimistic regarding the future for bladder cancer patients as there has been a tremendous increase in recognition, research and impactful drug development over the past decade. ” – Dr. Taylor